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Deriving lung progenitors from patient-specific
pluripotent cells is a key step in producing differenti-
ated lung epithelium for disease modeling and trans-
plantation. By mimicking the signaling events that
occur during mouse lung development, we gener-
ated murine lung progenitors in a series of discrete
steps. Definitive endoderm derived from mouse
embryonic stem cells (ESCs) was converted into
foregut endoderm, then into replicating Nkx2.1+
lung endoderm, and finally into multipotent embry-
onic lung progenitor and airway progenitor cells.
We demonstrated that precisely-timed BMP, FGF,
andWNT signaling are required for NKX2.1 induction.
Mouse ESC-derived Nkx2.1+ progenitor cells formed
respiratory epithelium (tracheospheres) when trans-
planted subcutaneously into mice. We then adapted
this strategy to produce disease-specific lung
progenitor cells from human Cystic Fibrosis induced
pluripotent stem cells (iPSCs), creating a platform for
dissecting human lung disease. These disease-
specific human lung progenitors formed respiratory
epithelium when subcutaneously engrafted into
immunodeficient mice.
INTRODUCTION
Thediscoveryof embryonic stemcells (ESCs) and inducedplurip-
otent stem cells (iPSCs) has resulted in an unprecedented oppor-
tunity to produce tissue-specific cell types that can be used in
human disease modeling, drug screening, and patient-specific
therapies. Generating disease-specific lung epithelial cells from
human lung disease-specific iPSCs is particularly important
because murine models of lung disease often do not phenocopy
human lung disease. A prime example of the failure of mousemodels to mimic human disease is the Cftr knockout mouse
that does not display the Cystic Fibrosis (CF) disease-associated
lung pathology observed in human patients (Snouwaert et al.,
1992; Clarke et al., 1992; Guilbault et al., 2007). Extraordinary
experiments have created new animal models of CF in both the
ferret and the pig nearly 2 decades after the CFTR gene was
cloned (Rogers et al., 2008; Stoltz et al., 2010; Sun et al., 2010;
Kerem et al., 1989; Riordan et al., 1989). These heroic experi-
ments allow the modeling of CF at a whole-animal level.
The work presented herein is an attempt to add a human
model system to these remarkable prior efforts. Although it
does not permit the analysis of the disease in the full animal
context, the iPSC systemwill allow patient specificity. It is known
that many patients with the same CFTR mutations do not have
a similar clinical course (Kerem et al., 1990, 1992; Cutting,
2005). Some of this variability is thought to result from disease-
modifying genes (Drumm et al., 2005; Haston and Hudson,
2005; Knowles, 2006). Using patient-specific iPSCs from
patients such as these will permit the study of CF clinical vari-
ability in the laboratory without the need to identify these genes
beforehand. Building on the remarkable recent success of the
first drug to target the CFTR channel defect directly in patients
with the rare G551D mutation (Accurso et al., 2010), it is clear
how this iPSC-based system could serve as a platform for
finding therapeutics for every patient with CF.
Although many iPSCs from patients with lung diseases are
currently being produced, the major obstacle preventing the
actual development of human lung disease models using these
cells is the inability to convert them into lung progenitors and
subsequently into differentiated pulmonary epithelial cell types.
Several attempts to produce pulmonary epithelial cells from
mouse and human ESCs have been made. Most investigators
have focused on the generation of type II pneumocytes (Van
Vranken et al., 2005; Samadikuchaksaraei et al., 2006; Wang
et al., 2007). Fewer studies have targeted the differentiation of
airway epithelial cells from pluripotent stem cells despite the
fact that airway diseases such as asthma, CF, bronchitis, and
bronchogenic carcinoma are, in aggregate, more prevalent
than the diseases of the alveoli such as emphysema.Cell Stem Cell 10, 385–397, April 6, 2012 ª2012 Elsevier Inc. 385
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Figure 1. Anteriorization of Endoderm to Foregut Endoderm Promotes Nkx2.1+ Cell Differentiation
(A) Administration of 20 ng/ml BMP4, 20 ng/ml FGF2, and 5 nM GSK3iXV to definitive endoderm resulted in hindgut differentiation with CDX2 expression, and
minimal NKX2.1 induction. Scale bar, 50 mm.
(B) Definitive endodermwas treated with different combinations of BMP4/TGFb agonists and antagonists as listed in the table for 2 days. The Foxa2+/Sox2+ cells
were quantified as a percentage of positive cells out of the total number of Foxa2+ cells. The cells were further treated with 20 ng/ml BMP4, 20 ng/ml FGF2, and
5 nM GSK3iXV to induce NKX2.1 expression. The percentage of Nkx2.1+ cells was quantified as a percentage of the total cells present. All data were averaged
from three independent experiments.
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generate functional pulmonary epithelium from ESCs were
characterized by the stochastic production of limited numbers
of cells and the generation of mixed cell populations, which
contain undifferentiated pluripotent stem cells that carry a
significant risk of teratoma formation after transplantation.
Others have utilized incompletely defined media to induce
respiratory cell differentiation (such as exposure of human
ESCs to tumor cell extract; Roszell et al., 2009) or have used
genetically modified pluripotent stem cells that were selected
based upon the presence of a drug resistance gene (Wang
et al., 2007). Unfortunately, genetic modulation raises the possi-
bility of the introduction of deleterious mutations in the resulting
cells.
Our overall strategy is to employ a stepwise differentiation
approach that mimics the timing and coordination of the
signaling pathways that guide lung development. Since there is
limited data concerning the embryonic signaling pathways that
regulate human lung organogenesis, we hypothesized that
human lung organogenesis is, in part, analogous to mouse
organogenesis. Therefore, knowledge of mouse lung develop-
ment can serve as a roadmap to guide human iPSC differentia-
tion strategies. Mechanisms that regulate mouse embryonic
endoderm regionalization, lung specification, and subsequent
progenitor patterning and growth have been well studied
(reviewed in Morrisey and Hogan, 2010). The onset of lung spec-
ification within the endoderm is accompanied by Nkx2.1 expres-
sion and the downregulation of Sox2 along the dorsal-ventral
axis of the gut tube (Lazzaro et al., 1991; Minoo et al., 1999;
Que et al., 2009). Later, Sox2 expression again increases in the
area of the future trachea, bronchus, and bronchioles. The
Nkx2.1+Sox2+ cells in this region of the embryonic lung are
airway progenitor cells that give rise to the mature airway epithe-
lium (Que et al., 2009). In contrast, Sox9, FoxP2, and ID2 are
expressed in the distal embryonic lung bud tip and mark a multi-
potent embryonic lung progenitor population (Perl et al., 2005;
Shu et al., 2007; Rawlins et al., 2009) capable of producing all
of the cell types of the airway and alveoli. We report the differen-
tiation of these two early progenitor cell populations frommouse
and human pluripotent stem cells.
Because Nkx2.1 is the earliest marker of lung endoderm dis-
tinguishing it from the rest of the foregut endoderm, we have
focused on producing Nkx2.1+ lung endoderm that is devoid
of Nkx2.1+ thyroid endoderm and neuronal progenitors. A recent
report using human ESCs demonstrated that a differentiation
strategy based on mimicking mouse gut organogenesis led to
the production of anterior foregut cells and Nkx2.1+ cells with
efficiencies up to 30% (Green et al., 2011). However, these
Nkx2.1+ cells were not demonstrated to be composed of purely
lung progenitors. TUJ1 (a marker of neuronal tissue) and PAX8
(a marker of thyroid tissue) expression was not evaluated at
the single-cell level by antibody costaining with an Nkx2.1 anti-
body. Development of a novel strategy to produce Nkx2.1+
progenitors that reflect only lung and not thyroid or brain differ-(C) Representative immunofluorescence staining showing Foxa2+ and Sox2+ do
100 mm.
(D) Representative immunofluorescence staining showing NKX2.1 induction fro
2 days. Scale bar, 100 mm.entiation is therefore needed (Watanabe et al., 2005), and the
technique must be applicable to human disease-specific iPSCs
in order for the technique to become widely relevant to the study
of human lung disease.
Building on the aforementioned studies, we report an efficient
and consistent step-wise differentiation method to generate
definitive endoderm (DE), foregut endoderm, early lung endo-
derm, multipotent Nkx2.1+ embryonic lung progenitor cells,
and airway progenitor cells beginning with mouse ESCs and
subsequently with lung disease-specific human iPSCs. We
show that a high dose of Activin, transient WNT activation, and
staged BMP4 inhibition converts ESCs into DEwith high efficien-
cies. Further inhibition of TGFb alone is sufficient to ‘‘anteriorize’’
endoderm into Sox2+ foregut endoderm. We show that this
anteriorization of the endoderm to foregut endoderm enhances
the ultimate differentiation of Nkx2.1+ cells at later steps of the
strategy. BMP4, FGF2, and WNT are each necessary for induc-
tion of the Nkx2.1+ immature lung progenitors. These early
progenitors can mature into Nkx2.1+Sox2+ proximal progenitor
cells and Nkx2.1+p63+ airway basal stem cells in vitro, and
can differentiate into airway epithelium. A modification of this
strategy was used to produce human disease-specific immature
airway epithelium derived from CF iPSCs, creating a new plat-
form for dissecting human lung disease.
RESULTS
Stage-Specific TGFb Inhibition Regionalizes Naive
Endoderm to Anterior Foregut Endoderm and Facilitates
the Differentiation of Nkx2.1+ Cells
A recent report described a monolayer-based strategy using
synergistic activation of Nodal and Wnt-b-catenin signaling as
well as staged BMP4 inhibition to direct mouse ESCs toward
an endoderm fate with high efficiency (Sherwood et al., 2011).
Here, we adapted this technology to generate DE from mouse
ESCs (Figure S1A available online). This protocol resulted in
a remarkable 80%–90% of cells being converted into DE based
on the dual expression of the endoderm transcription factors
FOXA2 and SOX17 (Figure S1B). Next, we asked if the newly
generated DE cells have the competence to generate Nkx2.1+
cells. After culturing them for 2 days in serum-free medium con-
taining BMP4, FGF2, and GSK3iXV (a WNT agonist) (Figure 1A),
we observed that less than 1% of the cells were Nkx2.1+ (Fig-
ure 1A). However, more than 60% of the cells were Cdx2+, sug-
gesting that the majority of the cells were specified to a hindgut
fate (Figure 1A). Because the endoderm cells at this stage did not
efficiently differentiate into Nkx2.1+ cells, we sought to test if an
‘‘anteriorization’’ step would facilitate lung fate specification.
Snoeck and colleagues reported that Noggin (BMP inhibitor)
synergized with SB431542 (a TGFb inhibitor) to suppress
a posterior endoderm fate (Cdx2+) in favor of an anterior endo-
derm fate (Sox2+) (Green et al., 2011). Because we had already
incorporated BMP inhibition during DE generation (Figure S1A),
we asked whether continuous BMP inhibition is necessary foruble positive cells after 2 days of treatment with 500 nM A-83-01. Scale bar,
m A-83-01 treated endoderm cells after BMP4/FGF2/GSK3iXV treatment for
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rior patterning. Hence, we treated endoderm with combinations
of Activin (TGFb agonist), A-83-01 (TGFb antagonist), BMP4,
and Dorsomorphin (BMP4 antagonist) for 2 days (Figure 1B).
We then compared the number of FoxA2+Sox2+ anterior endo-
derm cells to the total number of FoxA2+ endoderm cells
(Figure 1B). We also exposed the treated cells to the BMP4/
FGF2/WNT agonist cocktail for another 2 days to examine their
competence to generate Nkx2.1+ cells (Figure 1B). Our results
revealed that TGFb inhibition itself was sufficient to increase
FoxA2+Sox2+ anterior endoderm (40%–55%, compared to
<0.1% in medium alone; Figures 1B and 1C) and enhance the
competence of endoderm cells to form Nkx2.1+ cells (7%–
13% as compared to <1% without regionalization; Figures 1B
and 1D). We observed that continuous Activin treatment resulted
in rare FoxA2+Sox2+ cells and few Nkx2.1+ cells (Figure 1B),
suggesting that the optimal duration of Activin exposure was
important. We also found that additional BMP4 inhibition was
not required for the generation of FoxA2+Sox2+ cells and ulti-
mately may result in slightly lower percentages of Nkx2.1+ cells
(Figure 1B). We also observed less neuroectodermal marker
TUJ1 if BMP4 was present between days 5 to 7 (data not
shown), in agreement with the finding that BMP4 suppresses
neuronal commitment and promotes nonneural lineage differen-
tiation from ESCs (Zhang et al., 2010). FGF and WNT signaling
have been shown to maintain hindgut identity and actively
repress foregut endoderm differentiation (Wells and Melton,
2000; Ameri et al., 2010). Therefore, we also tested if their
inhibition would enhance anteriorization together with a TGFb
inhibitor. Subsequent experiments revealed that an FGF antago-
nist (PD173074) induced cell death, while a WNT antagonist
(IWR-1) did not increase the FoxA2+Sox2+ population (data not
shown).
Mouse ESC-Derived Nkx2.1+ Cells Are Devoid
of Neuronal and Thyroid Markers, Are Proliferative,
and Contain Distal Multipotent Lung Progenitors
and Proximal Airway Progenitors
Nkx2.1 is not a specific marker of the lung, and its expression is
also found in the thyroid and ventral forebrain (Figure S2A).
Therefore, it was important to determine the identity of the
Nkx2.1+ cells generated in our culture system. Unfortunately,
there are no reliable markers of the lung lineage at embryonic
stage E9 that are not expressed in the brain or thyroid. Surfactant
protein C (Sp-C), which is the most specific marker for lung
epithelial progenitors, is not detected until E10–E11 (Wert
et al., 1993). SOX9 and FOXP2 are indeed coexpressed with
NKX2.1 in distal lung multipotent epithelial progenitor cells (Fig-
ure S3B) and are not found in brain or newly specified thyroid
(Figure S2B and data not shown), but their expression is not
evident until after E11–E12. SOX2, on the other hand, is ex-
pressed in the E9 lung endoderm (Figure S2A) and later in airway
epithelial progenitors (Figures S3A and S3B), but SOX2 can also
be found in NKX2.1-expressing cells in ventral forebrain (Figures
S2A and S2C). Thus, at the earliest stage of lung endoderm
specification (E8.75–E9), none of these markers (SPC, SOX2,
SOX9, or FOXP2) can be used to reliably and uniquely identify
lung cells. In contrast, TUJ1 expression in Nkx2.1+ cells in
ventral forebrain begins at E8.0 and continues to be present388 Cell Stem Cell 10, 385–397, April 6, 2012 ª2012 Elsevier Inc.thereafter in ventral forebrain and not in thyroid or lung (Figures
S2B and 2C), making Tuj1 expression a specific indicator of
neuronal cell identity within the NKX2.1 domain. PAX8 expres-
sion is detected in the primordial thyroid at E8.75 at the time of
thyroid specification (Figure S2B), but not in the lung or brain.
Therefore, PAX8 can be used as a specific indicator of thyroid
cell identity in the NKX2.1 domain (Figures S2B and S2C).
In summary, we conclude that at the early specification stage,
we can regard Nkx2.1+/Tuj1–/Pax8– cells as likely to be of
lung cell lineage. Accordingly, we interrogated our ESC-derived
Nkx2.1+ cells for TUJ1 and PAX8 expression to exclude
neuronal and thyroid identity (Figure 2A). As expected for
any Nkx2.1+ cell in the embryo (thyroid, lung, and ventral
forebrain), all of our ex vivo differentiated Nkx2.1+ cells cos-
tained with FOXA2 (Figure 2A). We detected a small subset of
Tuj1+ cells in the cultures, but these neuronal cells did not over-
lap with the Nkx2.1+ cells (Figure 2A). We did not detect any
Pax8+ cells in our culture (Figure 2A; Figure S2B and data not
shown). Therefore, this suggests that the Nkx2.1+ cells that we
differentiate in vitro represent lung endoderm cells. These
Nkx2.1+ cells are proliferative, with more than half expressing
Ki67 (Figure 2B).
In themouse,Sox2 is rapidly downregulated in the foregut pre-
lung endoderm just as Nkx2.1 expression initiates in this same
prelung endoderm during the process of lung specification at
E9 (Figure S3A). Thus the very earliest lung endoderm cells are
Nkx2.1+ and Sox2-low cells. Soon thereafter, sustained high-
level SOX2 expression is detected in the proximal airway epithe-
lial progenitors of the future trachea, bronchus, and bronchioles
during the process of branching morphogenesis (Figures S3A
and S3B). Airway progenitors are therefore Nkx2.1+Sox2+. In
contrast, SOX9 and FOXP2 are expressed exclusively in the
distal tip multipotent lung progenitor cells (Figure S3B), making
SOX9 and FOXP2 markers that uniquely identify a distinct popu-
lation of multipotent embryonic lung progenitor cells within the
NKX2.1 domain because they are not present in the proximal
airway progenitors or the thyroid or brain as mentioned above.
Therefore, we checked if our ESC-derived Nkx2.1+ cells at
day 9 contained both proximal airway (Nkx2.1+Sox2+) and distal
multipotent (Nkx2.1+Sox9+; or Nkx2.1+FoxP2+) progenitor
cells. We counted the Nkx2.1+ cells generated from 10 indepen-
dent experiments. The average proportion of airway progenitor
cells (Nkx2.1+Sox2+) was 1.8% ± 0.8% out of the total
Nkx2.1+ cells, while the proportions of distal multipotent progen-
itor cells, Nkx2.1+Sox9+ or Nkx2.1+FoxP2+, were 4.8% ± 2.5%
and 6.6% ± 3.1% out of total Nkx2.1+ cells, respectively. The re-
maining Nkx2.1+ cells (not thyroid or neuron are cells with
minimal SOX2 expression and may reflect early prelung endo-
derm. Thus, themajority of Nkx2.1+ cells at day 9 likely represent
an early lung endoderm that has not been specified to an airway
progenitor or a distal tip multipotent lung progenitor population.
Figure 2C shows representative fields of cells enriched in
Nkx2.1+Sox2+, Nkx2.1+Sox9+, and Nkx2.1+FoxP2+ cells. In
aggregate, these results imply that ESC-derived Nkx2.1+ cells
at day 9 were immature, with most lacking proximal and
distal progenitor cell markers, likely representing early lung
endoderm cells. Although rare, the existence of Nkx2.1+Sox2+,
Nkx2.1+Sox9+, and Nkx2.1+FoxP2+ cells suggested that the
ESC-derived Nkx2.1+ lung endoderm cells were differentiating
AB
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Figure 2. ESC-Derived Nkx2.1+ Cells Are Devoid of Neuronal and Thyroid Markers, Are Proliferative, and Possess Markers of Proximal and
Distal Lung Endoderm
(A) Immunofluorescence staining for FOXA2, TUJ1, and PAX8 showing that Nkx2.1+ cells are positive for endodermal marker FOXA2, negative for neuro-
ectodermal marker TUJ1 (white arrow), and negative for thyroid marker PAX8. Scale bar, 50 mm.
(B) Nkx2.1+ cells were proliferative as demonstrated by costaining for KI67. Scale bar, 100 mm.
(C) Representative immunofluorescence staining showing subpopulations of Nkx2.1+ cells are positive for SOX2 (an airway progenitor marker) and FOXP2/SOX9
(multipotent lung progenitor marker). Scale bar, 100 mm.
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itor cells that could later be differentiated into mature epithelial
cells.
The expression of lung and other anterior cell fate lineage
genes including FoxN1 (thymus), Pax8 (thyroid), and Pax9 and
Tbx1 (pharyngeal pouch endoderm) was analyzed by real-time
qPCR (Figure S4A). As expected, the results showed that Sox2
was downregulated as pluripotent cells differentiated into DE.
Later, Sox2 levels increased in accord with the expectation
that anterior endoderm expresses Sox2. Nkx2.1, Sox9, and
FoxP2 expression was minimal in ESCs, DE, and anteriorized
endoderm, but was greatly increased (10–20 fold) after stimula-
tion with the FGF2/WNT/BMP4 induction cocktail, consistentwith previous results demonstrating these lung-specific marker
combinations by antibody staining (Figure 2C). Similarly,
FoxN1, Tbx1, Pax8, and Pax9 expression was low in ESCs, DE
and anteriorized endoderm. However, in growth-factor-induced
anterior foregut cells, we observed a modest increase in Pax9
and Tbx1 expression, whereas FoxN1 and Pax8 expression
was still very minimal. Despite the increase in Pax9 and Tbx1
gene expression, we did not detect any reproducible staining
for these proteins by immunofluorescence (data not shown). All
of these results are consistent with our finding that a combination
of FGF, BMP4, and WNT signaling predominantly drives the
differentiation of lung-specific Nkx2.1+ progenitor cells from
anterior endoderm.Cell Stem Cell 10, 385–397, April 6, 2012 ª2012 Elsevier Inc. 389
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Figure 3. BMP4, FGF2, and WNT Signaling Are Necessary for Lung
Specification from Foregut Endoderm Cells
(A) Schematic strategy and time frame to generate Nkx2.1+ cells from foregut
endoderm cells.
(B) NKX2.1 induction using various combinations of BMP4, FGF2, WNT, and
their antagonists.
(C) NKX2.1 percentage was scored as the number of Nkx2.1+ cells out of the
total cell number, average of three independent experiments.
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for NKX2.1 Induction In Vitro, Recapitulating Murine
Lung Development
Based on mouse genetic studies, BMP4, FGF2, and WNT
signaling are each required to specify lung endoderm from the390 Cell Stem Cell 10, 385–397, April 6, 2012 ª2012 Elsevier Inc.anterior foregut (Domyan et al., 2011; Goss et al., 2009; Serls
et al., 2005). Therefore, we tested if we could recapitulate these
findings in our in vitro mouse ESC differentiation system. To do
this, we exposed the anteriorized endoderm cells to combina-
tions of BMP4, FGF2, and WNT agonists and antagonists
(Figures 3A and 3B). We found that BMP4 alone could induce
NKX2.1 expression. In contrast, FGF2 or/and GSKiXV without
BMP4 was not sufficient for NKX2.1 induction, suggesting that
BMP4 signaling is required for lung specification (Figures 3B
and 3C). Interestingly, in the presence of FGF and WNT antago-
nists, BMP4 could no longer induce Nkx2.1+ cells. This result
implies an endogenous secretion of FGF and WNT ligands. It
also suggests that FGF and WNT activation are needed for
BMP4-dependent NKX2.1 specification (Figures 3B and 3C).
Despite presumptive endogenous FGF signaling, an increase
in FGF2 concentration upregulated Nkx2.1+ cell percentage,
which is in agreement with the finding that high doses of FGF2
promote lung fate from foregut (Figures 3B and 3C; Serls et al.,
2005). Compared to FGF2 signaling, exaggerated WNT activa-
tion was detrimental, with a decrease in Nkx2.1+ cells (Figures
3B and 3C) and an increase in hindgut Cdx2+ cells (data not
shown), consistent with the fact that WNT signaling is known
to posteriorize gut to hindgut prior to its effect on the lung (Sher-
wood et al., 2011).
BMP2, BMP4, and BMP7 are by far the most studied
members of the BMP family. Both BMP2 and BMP4 signal
through the type I receptor (ALK3), whereas BMP7 binds to
a separate type I receptor (ALK2) (reviewed by von Bubnoff
and Cho, 2001; Chen et al., 2004; Sieber et al., 2009; Miyazono
et al., 2010). We compared the effects of BMP2 and BMP7 to
BMP4 on induction of Nkx2.1+ cells from the anterior endo-
derm. Our results showed that BMP2 was less efficient than
BMP4 at inducing Nkx2.1+ cells, while BMP7 (10 ng/ml) had
no effect (Figure 4A). Even with an increased concentration
(>100 ng/ml), BMP7 still failed to generate Nkx2.1+ cells (data
not shown). This suggests that BMP7 signaling via the ALK2
receptor is not required for NKX2.1 induction. In canonical
BMP2/4 signaling, BMP2/4 binds to BMP receptor I/II complex,
leading to phosphorylation of Smad1/5/8, followed by formation
of heteromeric complexes with Smad4. These complexes trans-
locate to the nucleus and activate expression of target genes
(von Bubnoff and Cho, 2001; Chen et al., 2004; Sieber et al.,
2009; Miyazono et al., 2010). Besides Smad1/5/8-mediated
transcription, BMP-induced receptor complexes can activate
the mitogen-activated protein kinase (MAPK) pathway via
ERK, JNK, or p38 (Kozawa et al., 2002). Using Dorsomorphin
(a pSmad1/5/8 inhibitor) and PD98059 (a MAPKK/ERK inhibitor),
we observed that Dorsomorphin completely abrogated genera-
tion of Nkx2.1+ cells, while PD98059 only partially decreased
the Nkx2.1+ cell proportion (Figure 4A). We also observed
significant cell death in the presence of PD98059, so we could
not exclude the possibility that the decrease in Nkx2.1+ cells
was due to apoptosis. In addition, Smad and MAPK-mediated
pathways can be integrated (Aubin et al., 2004), and the
decrease in Nkx2.1+ cells in the presence of PD98059 might
also be due to a downregulation of Smad-dependent signaling.
Overall, we conclude that Smad-dependent BMP2/4 signaling
cascade is necessary for NKX2.1 specification from foregut
cells (Figure 4B).
AB
Figure 4. Smad-Dependent BMP Signaling Is Required for Lung
Differentiation
(A) NKX2.1 induction with 20 ng/ml FGF2 and 5 nM GSK3iXV only (control) or
with additional BMP4 (20 ng/ml), BMP2 (20 ng/ml), BMP7 (20 ng/ml), BMP4
(20 ng/ml) + 10 mMDorsomorphin, or BMP4 (20 ng/ml) + 1 mMPD98059. Scale
bar, 100 mm.
(B) BMP signaling through SMAD-dependent pathways is required for lung
Nkx2.1+ differentiation. In contrast, signaling through theMAP kinase pathway
is not required for Nkx2.1 expression. Dorsomorphin inhibits BMP signaling
through the SMAD pathway while PD98059 inhibits MAPK signaling.
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asWNT andMAPKK/ERK Inhibition, Generates Proximal
Airway Progenitors
As we demonstrated above, most ESC-derived Nkx2.1+ cells
at day 9 were immature lung endoderm cells. We therefore
continued to differentiate these cells in order to produce more
mature Nkx2.1+Sox2+ embryonic airway progenitors. We selec-
tively applied signaling factors to generate airway stalk progen-
itors from immature lung Nkx2.1+ cells (Figures 5A and 5B).
Multipotent Nkx2.1+Sox9+ tip progenitors replicate at the
lung bud tip and their progeny are laid down during the pseudo-
glandular phase of branching morphogenesis (E11 to E16.5)
to constitute the primitive airway tree and differentiate into
Nkx2.1+Sox2+ airway progenitors. BMP4 is expressed distally
and BMP7 is expressed around the airway, and distal FGF2
and FGF10 are replaced by proximal FGF7 (Weaver et al.,
1999; Bellusci et al., 1996; Lebeche et al., 1999; Powell et al.,
1998;Morrisey andHogan, 2010), while canonicalWNT signaling
is inhibited in the proximal stalk progenitors and present in
the distal tip (Shu et al., 2005; Okubo and Hogan, 2004).
Similarly, airway stalk cells are exposed to inhibitory Noggin
while the uncommitted tip cells are exposed to BMP4 (Weaver
et al., 1999; Que et al., 2006). Retinoic acid (RA) concentration
is relatively higher in the stalk region than at the tips (Malpel
et al., 2000). We therefore switched cells at day 9 to a ‘‘proximal
induction’’ medium prepared with RA-supplemented B27,
BMP7, FGF7, IWR-1 (WNT antagonist), and Noggin (Figure 5C,
left panel). After 2–3 days, we observed an increase in Nkx2.1+
Sox2+ airway progenitor cells. The proportion was 10% of
the total number of Nkx2.1+ cells, as compared to 1%–2%
before treatment. In separate experiments in which individual
growth factors were removed, we found that WNT antagonism
has the most pronounced effect on Nkx2.1+Sox2+ cell
production. Addition of Dorsomorphin (BMP antagonist) to
replace Noggin at this stage had little effect on the number of
Nkx2.1+Sox2+ cells. Interestingly, the small molecule PD98059
(aMAPKK/ERK inhibitor) enhanced generation of Nkx2.1+Sox2+
airway progenitor cells to up to 18% of the total number of
Nkx2.1+ cells (Figure 5C, right panel). This suggests that airway
progenitors may be formed after inhibition of a MAPKK/ERK-
related pathway. Most notably, we started to detect a small frac-
tion of Nkx2.1+p63+ cells (about 1%–4% of the total number of
Nkx2.1+ cells) at day 11–12 (Figure 5D). An increase in the dura-
tion of culture in the proximal induction medium from 2 to 5 or
more days resulted in higher proportions of Nkx2.1+Sox2+ and
Nkx2.1+p63+ cells (data not shown). Although the production
of Nkx2.1+Sox2+ and Nkx2.1+p63+ cells still needs to be opti-
mized, our results demonstrate that ESC-derived Nkx2.1+ cells
can be differentiated into proximal airway progenitors and con-
ducting airway basal cells.
ESC-Derived Nkx2.1+ Cell Populations
Can Differentiate into Mature Airway Epithelium
When Transplanted In Vivo
Nkx2.1+ lung progenitor cells derived from pluripotent stem cells
must possess the capacity to generate functional respiratory
epithelium to be useful. Therefore, we tested our mouse ESC-
derived Nkx2.1+ progenitors for their capacity to form mature
respiratory epithelium by subcutaneous engraftment (Figure 6).Cell Stem Cell 10, 385–397, April 6, 2012 ª2012 Elsevier Inc. 391
DA
B
C
Figure 5. Generation of Embryonic Airway Progen-
itors from Multipotent Lung Endoderm Cells
(A) Schematic strategy and time line to generate embryonic
airway progenitors from multipotent lung endoderm cells.
(B) Summary of signaling switches that are distinct in the
proximal airway and the distal lung bud tip during the
pseudoglandular stage of lung development.
(C) Left panel: NKX2.1 and SOX2 staining after treatment of
Nkx2.1+ lung endoderm cells at D9 with medium con-
taining RA-supplemented B27, 20 ng/ml BMP7, 20 ng/ml
FGF7, 100 nM IWR-1 (WNT antagonist), and 100 ng/ml
Noggin for 2 days. Right panel: NKX2.1 and SOX2 staining
after treatment of Nkx2.1+ lung endoderm cells at D9 with
medium containing RA-supplemented B27, 20 ng/ml
BMP7, 20 ng/ml FGF7, 100 nM IWR-1 (WNT antagonist),
and 1 mM PD98059 for 2 days. Scale bar, 50 mm.
(D) Immunofluorescence staining showing a subpopulation
of Nkx2.1+ cells positive for P63 (closed arrows). Scale
bar, 25 mm.
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progenitor cells from other cells, our assay evaluated the ability
of Nkx2.1+ cells to differentiate within a mixed cell population.
20,000–50,000 cells were suspended in 50% Matrigel and in-
jected under the skin of immunodeficient mice. Twenty to thirty
days after injection, engrafted tissues were excised for examina-
tion. We observed that many epithelial spheres formed within
grafts and that some of these spheres contained Nkx2.1-ex-
pressing cells. In some Nkx2.1+ spheres, we detected markers
of mature airway epithelial cells (Figure 6), including Sox2+ prox-
imal airway epithelial cells (Figure 6B), p63+ basal stem cells,
CC10+ Clara cells, FoxJ1+ ciliated cells, and Muc5ac+ mucin-
secreting cells (Figures 6C and 6D). Triple immunofluorescence
staining with confocal imaging demonstrated spheres that
contain more than one marker of mature airway epithelium.
Suchmature airway epithelial markers have never been detected
in ESC-derived teratomas. Previously published basal stem
cell differentiation using a 3D sphere-forming assay produced
ciliated and basal cells, but not Clara cells (Rock et al.,
2009). We did not detect any type I and type II pneumocyte
markers such as PRO-SPC, PRO-SPA, and AQUAPORIN5
despite having distal lung multipotent cells (Nkx2.1+Sox9+ and
Nkx2.1+FoxP2+) in the initial cell mixture. Overall, we concluded392 Cell Stem Cell 10, 385–397, April 6, 2012 ª2012 Elsevier Inc.that ESC-derived Nkx2.1+ cell-containing popu-
lations are capable of airway epithelial cell
differentiation.
An Efficient and Reproducible Stepwise
Approach to Generate NKX2.1+ Lung
Cells from Human CF iPSCs
Next, we examined whether a similar stepwise
differentiation approach could be used to
generate lung airway progenitors from CF
disease-specific human iPSCs (Figure 7A). All
differentiation steps were performed in xeno-
free conditions. Furthermore, two of the CF
iPSC lines were generated using modified
RNAs (RiPSC) rather than virally encoded re-
programming factors (Warren et al., 2010) andthus were genetically unmodified, another advantage for
possible future clinical use. CF iPSCs were maintained on
Geltrex-coated plates in complete mTeSR1medium. High yields
of DE were obtained after treatment for 3–4 days in RPMI-1640
medium in the presence of Activin (100 ng/ml) and PI3 kinase
inhibitor LY294002 (5 mM). More than 85%–90% of cells coex-
pressed the transcription factors SOX17 and FOXA2 at day 4,
demonstrating very efficient production of DE from a RiPSC
line that is compound heterozygous for CFTR mutant alleles
DF508 and G551D (Figure 7B). This protocol was also success-
fully applied to other human pluripotent cells including three CF
iPSC lines homozygous for the DF508 allele, a wild-type human
BJ RiPSC line (Warren et al., 2010), and the HUES-3 andHUES-9
human ESC lines (data not shown).
By using anteriorization conditions similar to those used by
Green et al., we were able to induce SOX2 expression in DE cells
with efficiencies of up to 50%–60%after 4 days of treatment with
A-83-01 (a TGFb antagonist; Figure 7C). We found that Noggin
(a BMP4 antagonist) was actually not necessary for this anterio-
rization. Similar combinations of growth factors and agonists
(BMP4, FGF2, and GSK3iXV) identified in our studies on mouse
ESCs could be used to generate Nkx2.1+ cells with efficiencies
of 10%–30% (Figure 7D). These Nkx2.1+ cells were negative for
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Figure 6. Differentiation of Airway Epithelium from Mouse-ESC-
Derived Lung Endoderm upon Subcutaneous Engraftment
(A) Schematic strategy and time line to differentiate ESC-derived embryonic
airway progenitors.
(B) Immunofluorescence staining showing that some Nkx2.1+ cells are posi-
tive for SOX2. Scale bar, 100 mm.
(C) Immunofluorescence staining showing differentiation of ESC-derived
Nkx2.1+ cells into p63+ airway basal stem cells, CC10+ Clara cells, FoxJ1+
ciliated cells, and Muc5ac+ goblet cells. The arrow points to a representative
positive cell for each category. Scale bar, 100 mm.
(D) Confocal imaging showing differentiation of various airway epithelial cells.
Scale bar, 100 mm.
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neuronal or thyroid identity. In addition, subpopulations of these
Nkx2.1+ cells were also positive for SOX2 and SOX9 (Figure 7D).
These markers suggest the presence of both committed airway
progenitors (Nkx2.1+Sox2.1 cells) and multipotent embryonic
lung progenitors (Nkx2.1+Sox9+ cells).
We also quantified the expression of various anterior cell fate
genes by qPCR (Figure S4) and observed very similar gene
expression patterns to those seen in mouse ESC differentiation.
SOX2 was downregulated after differentiation into DE and then
increased as expected after anteriorization. We again observed
dramatic upregulation of NKX2.1, SOX9, and FOXP2 expression
(20–30 fold) in anteriorized endoderm cells after FGF2/BMP4/
WNT induction. The expression of other anterior cell fate genes
including PAX8 (thyroid endoderm), PAX9 (pharyngeal endo-
derm), and TBX1 (pharyngeal endoderm anterior to lung/esoph-
agus) was only modestly upregulated without any expression of
FOXN1 (thymus endoderm) (Figure S5). In aggregate, the differ-
entiation spectrum of the endoderm was remarkably similar in
the mouse and human platforms.Finally, human RiPSC-derived Nkx2.1+mixed cell populations
were subcutaneously engrafted (Figure 7E). Many spheres
formed in engrafted tissues after 30 days under the skin of
immunodeficient recipient mice. In Nkx2.1+ spheres, some of
the Nkx2.1+ cells coexpressed p63, suggesting that these
Nkx2.1+ cells had matured into airway basal stem cells (Fig-
ure 7E). Further differentiation into ciliated cells, Clara cells,
and mucin-secreting goblet cells was not detected, indicating
that further optimization of differentiation conditions is required.
DISCUSSION
We report a stepwise developmentally guided strategy to differ-
entiate murine pluripotent stem cells into lung multipotent
progenitors and airway progenitors that produced respiratory
epithelium when engrafted subcutaneously into a mouse. We
then adapted our strategy to produce disease-specific lung
progenitor cells from human CF iPSCs and other human plurip-
otent stem cell lines, thus creating a platform for dissecting
human lung disease.
Additionally, we show that pluripotent stem cell systems can
be used as a discovery tool to investigate steps in lung develop-
ment. We were able to independently confirm recent mouse
developmental genetics findings demonstrating that BMP4 is
essential for lung specification, as well as similar studies that
show that canonical WNT signaling is necessary for lung bud
specification (Domyan et al., 2011; Goss et al., 2009). We also
demonstrate that FGF signaling in addition to BMP and WNT
signaling is required in the current culture system for NKX2.1
induction, an observation that has proven difficult to define in
murine genetic systems due to the presence of multiple FGFs
in the vicinity of the foregut lung anlage. Mechanistic dissection
of the BMP4 signaling effect also revealed an observation that
BMP4 signaling occurs through a Smad-dependent pathway
and that pharmacologic Smad modulation enhances Nkx2.1+
lung cell differentiation. We have also shown that the carefully
timed staged antagonism or agonism of the same pathway is
essential to drive optimal differentiation. The premature addition
of WNT signals that are later necessary for Nkx2.1+ lung cell
induction at the endoderm stage, for example, regionalizes
endoderm to a hindgut intestinal epithelium and prevents the
differentiation of Nkx2.1+ cells (Spence et al., 2011; Cao et al.,
2011; Sherwood et al., 2011). Thus, not only combinations of
signaling cascades, but also their precise timing, are essential
to recapitulate in vivo differentiation.
Although we report differentiation of Nkx2.1+Sox2+ proximal
airway progenitors and Nkx2.1+p63+ double-positive airway
stem cells derived from both human and mouse pluripotent
stem cells, the proportions of Nkx2.1+ lung and airway progen-
itors are low. This might reflect an intrinsic bias in the differenti-
ation of our iPSCs. It is also possible that other pathways coop-
erate with FGF, BMP, and WNT signaling cascades to effect
Nkx2.1+ endoderm differentiation or, conversely, that other
pathways need to be inhibited. Zaret and colleagues have sug-
gested that the anterior gut contains an epigenetic prepattern
that regulates the ability of gut endoderm to differentiate into a
particular tissue despite the presence of the correct growth fac-
tors (Zaret et al., 2008). Perhaps many of the iPSC-derived fore-
gut endoderm cells do not possess the epigenetic prepatternCell Stem Cell 10, 385–397, April 6, 2012 ª2012 Elsevier Inc. 393
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Figure 7. Stepwise Differentiation of Nkx2.1+ Lung Progenitors from Human iPSCs
(A) Schematic strategy and time line to generate Nkx2.1+ lung multipotent progenitors from human iPSCs.
(B) High yield of definitive endoderm from CF1 RiPSCs was obtained after treatment for 4 days in RPMI-1640 medium in the presence of 2% B27 supplement,
Activin A (100 ng/ml), and 5 mM PI3 Kinase inhibitor LY294002 with more than 90% of cells coexpressing transcription factors SOX17 and FOXA2. Scale bar,
200 mm.
(C) Anteriorization of endoderm into foregut endoderm cells with SOX2 expression in Foxa2+ cells derived fromCF1RiPSCs after 4 days of treatment with 500 nM
A-83-01 (TGFb antagonist) and 100 ng/ml Noggin (BMP4 antagonist). Scale bar, 100 mm.
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Lung Endoderm/Progenitors from ESCs and iPSCsthat would allow them to differentiate into Nkx2.1 cells. Addition-
ally, it must be determined whether Nkx2.1+ progenitor cells
expanded in culture undergo modifications that permit the
expression of thyroid or neuronal genes. It will be important to
investigate each of these possibilities so that we can rationally
increase the efficiency of the differentiation protocols described
herein by overcoming the relevant mechanistic hurdles. Ulti-
mately, we will need protocols that will be effective for any
human iPSC line and reagents to be able to sort pure populations
of human cells in the absence of genetic reporters or selectable
drug resistance genes. Our strategy can then in principle be
applied to any human lung disorder.
Finally, conditions must be found to affect the maturation of
iPSC-derived lung epithelium ex vivo. To study an airways
disease like CF and to screen for small molecule therapeutics
using iPSC-derived cells, we will require an Nkx2.1+ epithelium
that contains all of the appropriate human cellular constituents.
That same epitheliummust display functional coordinated ciliary
beating, epithelial secretory function (including regulated CFTR-
mediated chloride ion transport and mucus secretion), and an
airway stem cell-driven capacity for epithelial regeneration.
EXPERIMENTAL PROCEDURES
Mice and Human Cell Lines
NOD-SCID IL2Rgamma null (NOD/SCIDIl2rg/) immunodeficient mice were
purchased from Jackson Laboratory. Animal procedures were performed in
accordance with Massachusetts General Hospital (MGH) and national guide-
lines and regulations and were approved by the Institutional Animal Care and
Use Committee (IACUC) for MGH. The use of human CF induced-pluripotent
cell lines and embryonic cell lines (HUES-3 and HUES-9) was reviewed and
approved by the Embryonic Stem Cell Research Oversight committee
(ESCRO) and IRB at MGH.
Mouse Endoderm Anteriorization and Nkx2.1 Cell Differentiation
Mouse DE was generated as described in Supplemental Experimental Proce-
dures. To anteriorize endoderm, on and after day 5, the cells were split
and reseeded on to the plates precoated with 804G-conditioned medium
and fed with D0 medium + 0.5–1 mM A8301 (CalBiochem, 616454) for
2 days. Then the medium was rinsed with D0 medium two times and switched
to D0 medium supplemented with 50 ng/ml BMP4, 100 ng/ml FGF2
(GIBCO, PHG0026), and 5–10 nM GSK3iXV for another 2–3 days. To generate
Nkx2.1+Sox2+ proximal progenitor cells, the cells were rinsed with D0
medium two times and switched to D0 medium containing RA-supplemented
B27, 50 ng/ml BMP7, 50 ng/ml FGF7, 100 nM IWR-1, and 1–2 mMPD98059 for
2 days or longer.
Human iPSC Culture and Differentiation
Human iPSCs were maintained on Geltrex-coated plates in complete mTeSR1
medium (Stemcell). High yields of DE progenitors were obtained after treat-
ment for 3–4 days in RPMI-1640 medium in the presence of 2% B27 supple-
ment minus vitamin A (GIBCO, 12587-010), Activin A (Peprotech, 100 ng/ml)
and PI3 Kinase inhibitor LY294002 (5 mM). To generate foregut endoderm cells,
DE was treated for 4 days with RPMI-1640 medium containing 2% B27 and
500 nM A-83-01 (TGFb antagonist) with or without Noggin (BMP4 antagonist,
100 ng/ml) or Dorsomorphin (2–5 mM). After that, the cells were exposed for
4 days or longer to RPMI-1640 medium containing 2% B27, 50 ng/ml
BMP4, 100 ng/ml FGF2, and 5 nM GSK3iXV for NKX2.1 induction from endo-
derm cells.(D) Left panel: NKX2.1 staining after anteriorization to foregut cells at D8 with seru
for 4 days. Scale bar, 100 mm. Right panel: costaining of Nkx2.1-positive cells w
neuronal differentiation and the presence of multipotent distal tip progenitors an
(E). Confocal image after immunofluorescence staining showing that some Nkx2Immunofluorescence
At each differentiation step, the cells were fixed with fresh paraformaldehyde
(4%) for 15 min at room temperature, rinsed in PBS, washed with PBS + 0.2%
Triton X-100, and incubated with the primary antibodies at 4C overnight
(>16 hr) diluted in PBS + 1% BSA. Following incubation, the cells were rinsed
four times in PBS + 0.2% Triton X-100, and incubated with secondary anti-
bodies at room temperature for 2 hr. The images were visualized using an
Olympus IX71 inverted fluorescencemicroscope or a Nikon A1 Confocal Laser
microscope. The primary antibodies used are summarized in Table S2. The
secondary antibodies were purchased from Invitrogen (Alexa Fluor 549 and
Alexa Fluor 488). The quantification was performed by counting at least five
random fields at 203magnification and calculating the average and standard
deviation.
Embryo Harvest, Section Cutting, and Staining
The embryos or lungs at desired embryonic stages were dissected out and
fixed at 4C for 6 hr or overnight with fresh 4% PFA. Then tissues were rinsed
with PBS for 3min (5min per time) and incubated in 30%sucrose in PBS at 4C
overnight. The tissues were soaked in OCT for 1 hr and then frozen in OCT for
cryosectioning at 7 mm thickness. The slides were stained with the primary and
secondary antibodies as described above.
Differentiation of Mouse ESC and Human iPSC-Derived Nkx2.1+
Lung Progenitors after Subcutaneous Engraftment
Anywhere from 23105 to 53105 cells were suspended in 200 ml 1:1 mixture of
Growth Factor Reduced Matrigel (BD Biosciences, 354230) and Advanced
DMEM and were injected subcutaneously into NOD/SCIDIl2rg/ null mice.
The tissues were harvested and examined after 20–30 days, fixed overnight
in cold 4% paraformaldehyde, rinsed two times with PBS, soaked in 30%
sucrose for 2–3 hr, embedded in OCT, and sectioned at 7 mm. The slides
were examined for airway epithelial cells based on NKX2.1 expression. The
differentiation of ESC-derived Nkx2.1+ cells into basal stem cells was based
on expression of P63 and CK5; goblets cells, based on expression of
MUC5AC; Clara cells, based on expression of CCSP; and ciliated cells, based
on the expression of FOXJ1.
Additional Culture Information
For more information on how to culture these cells, please refer to the Rajago-
pal Lab website: http://www.massgeneral.org/regenmed/staff/Rajagopallab.
We intend to deposit the reported cells in the Harvard Stem Cell Institute iPS
Cell Core Facility (please see http://www.hsci.harvard.edu/ipscore/node/3).
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, two tables, and Supple-
mental Experimental Procedures and can be found with this article online at
doi:10.1016/j.stem.2012.01.018.
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